Zolopa AR - Search Results

1

Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors.

Gonzales MJ, Wu TD, Taylor J, Belitskaya I, Kantor R, Israelski D, Chou S, Zolopa AR, Fessel WJ, Shafer RW. Gonzales MJ, et al. Among authors: zolopa ar. AIDS. 2003 Apr 11;17(6):791-9. doi: 10.1097/00002030-200304110-00003. AIDS. 2003. PMID: 12660525 Free PMC article.

2

Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility.

Melikian GL, Rhee SY, Taylor J, Fessel WJ, Kaufman D, Towner W, Troia-Cancio PV, Zolopa A, Robbins GK, Kagan R, Israelski D, Shafer RW. Melikian GL, et al. Antimicrob Agents Chemother. 2012 May;56(5):2305-13. doi: 10.1128/AAC.05487-11. Epub 2012 Feb 13. Antimicrob Agents Chemother. 2012. PMID: 22330916 Free PMC article.

3

Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage therapy.

Kantor R, Fessel WJ, Zolopa AR, Israelski D, Shulman N, Montoya JG, Harbour M, Schapiro JM, Shafer RW. Kantor R, et al. Among authors: zolopa ar. Antimicrob Agents Chemother. 2002 Apr;46(4):1086-92. doi: 10.1128/AAC.46.4.1086-1092.2002. Antimicrob Agents Chemother. 2002. PMID: 11897594 Free PMC article.

4

Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments.

Wu TD, Schiffer CA, Gonzales MJ, Taylor J, Kantor R, Chou S, Israelski D, Zolopa AR, Fessel WJ, Shafer RW. Wu TD, et al. Among authors: zolopa ar. J Virol. 2003 Apr;77(8):4836-47. doi: 10.1128/jvi.77.8.4836-4847.2003. J Virol. 2003. PMID: 12663790 Free PMC article.

5

Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation.

Gonzales MJ, Delwart E, Rhee SY, Tsui R, Zolopa AR, Taylor J, Shafer RW. Gonzales MJ, et al. Among authors: zolopa ar. J Infect Dis. 2003 Aug 1;188(3):397-405. doi: 10.1086/376534. Epub 2003 Jul 10. J Infect Dis. 2003. PMID: 12870121 Free PMC article.

6

HIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance.

Rhee SY, Fessel WJ, Zolopa AR, Hurley L, Liu T, Taylor J, Nguyen DP, Slome S, Klein D, Horberg M, Flamm J, Follansbee S, Schapiro JM, Shafer RW. Rhee SY, et al. Among authors: zolopa ar. J Infect Dis. 2005 Aug 1;192(3):456-65. doi: 10.1086/431601. Epub 2005 Jul 5. J Infect Dis. 2005. PMID: 15995959 Free PMC article.

7

N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure.

Mitsuya Y, Winters MA, Fessel WJ, Rhee SY, Hurley L, Horberg M, Schiffer CA, Zolopa AR, Shafer RW. Mitsuya Y, et al. Among authors: zolopa ar. AIDS Res Hum Retroviruses. 2006 Dec;22(12):1300-5. doi: 10.1089/aid.2006.22.1300. AIDS Res Hum Retroviruses. 2006. PMID: 17209774 Free PMC article.

8

Nonpolymorphic human immunodeficiency virus type 1 protease and reverse transcriptase treatment-selected mutations.

Shahriar R, Rhee SY, Liu TF, Fessel WJ, Scarsella A, Towner W, Holmes SP, Zolopa AR, Shafer RW. Shahriar R, et al. Among authors: zolopa ar. Antimicrob Agents Chemother. 2009 Nov;53(11):4869-78. doi: 10.1128/AAC.00592-09. Epub 2009 Aug 31. Antimicrob Agents Chemother. 2009. PMID: 19721070 Free PMC article.

9

Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment-experienced HIV-infected patients: impact on virological response to efavirenz-based therapy.

Shulman N, Zolopa AR, Passaro D, Shafer RW, Huang W, Katzenstein D, Israelski DM, Hellmann N, Petropoulos C, Whitcomb J. Shulman N, et al. Among authors: zolopa ar. AIDS. 2001 Jun 15;15(9):1125-32. doi: 10.1097/00002030-200106150-00007. AIDS. 2001. PMID: 11416714

10

HIV-1 protease mutations and protease inhibitor cross-resistance.

Rhee SY, Taylor J, Fessel WJ, Kaufman D, Towner W, Troia P, Ruane P, Hellinger J, Shirvani V, Zolopa A, Shafer RW. Rhee SY, et al. Antimicrob Agents Chemother. 2010 Oct;54(10):4253-61. doi: 10.1128/AAC.00574-10. Epub 2010 Jul 26. Antimicrob Agents Chemother. 2010. PMID: 20660676 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters